Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rahul Aggarwal

Showing results (31-40 of 222) with videos related to

Pageof 23
Sort By:
Journal of Cancer Research and Clinical Oncology|June 29, 2019
RRx-001 protects normal tissues but not tumors via Nrf2 induction and Bcl-2 inhibitionBryan Oronsky, Curtis Scribner, Rahul Aggarwal, et al.
Circulation. Cardiovascular Quality and Outcomes|October 9, 2025
Cardiovascular Risk Factor Management in Medicare Advantage and Traditional MedicareAndrew S Oseran, Rahul Aggarwal, Rishi K Wadhera
Hypertension (Dallas, Tex. : 1979)|May 9, 2019
Mortality Outcomes With Intensive Blood Pressure Targets in Chronic Kidney Disease PatientsRahul Aggarwal, Benjamin Petrie, Wasif Bala, et al.
JAMA Health Forum|August 17, 2022
Association of the Medicare Value-Based Purchasing Program With Changes in Patient Care Experience at Safety-net vs Non-Safety-net HospitalsNicholas Chiu, Rahul Aggarwal, Yang Song, et al.
Circulation. Heart Failure|December 10, 2021
Out-of-Pocket Costs for SGLT-2 (Sodium-Glucose Transport Protein-2) Inhibitors in the United StatesRahul Aggarwal, Muthiah Vaduganathan, Nicholas Chiu, et al.
Progress in Cardiovascular Diseases|September 24, 2021
Potential implications of the FDA approval of semaglutide for overweight and obese adults in the United StatesRahul Aggarwal, Muthiah Vaduganathan, Nicholas Chiu, et al.
Progress in Cardiovascular Diseases|September 4, 2025
Generalizability of SURPASS-CVOT to the United States: A Nationally Representative StudyRahul Aggarwal, Stephen J Nicholls, David D'Alessio, et al.
Dermatology (Basel, Switzerland)|July 14, 2025
Martian Dermatology: A Narrative Review of Dermatoses for Future ExplorersRyan Scheinkman, Rahul Aggarwal, Eran Gwillim, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2014
Neuroendocrine prostate cancer: subtypes, biology, and clinical outcomesRahul Aggarwal, Tian Zhang, Eric J Small, et al.
Therapeutic Advances in Medical Oncology|September 14, 2020
Dramatic response to combination pembrolizumab and radiation in metastatic castration resistant prostate cancerHarry J Han, Yun Rose Li, Mack Roach, et al.
Pageof 23

Showing results (31-40 of 222) with videos related to

Sort By:
Pageof 23
Journal of Cancer Research and Clinical Oncology|June 29, 2019
RRx-001 protects normal tissues but not tumors via Nrf2 induction and Bcl-2 inhibitionBryan Oronsky, Curtis Scribner, Rahul Aggarwal, et al.
Circulation. Cardiovascular Quality and Outcomes|October 9, 2025
Cardiovascular Risk Factor Management in Medicare Advantage and Traditional MedicareAndrew S Oseran, Rahul Aggarwal, Rishi K Wadhera
Hypertension (Dallas, Tex. : 1979)|May 9, 2019
Mortality Outcomes With Intensive Blood Pressure Targets in Chronic Kidney Disease PatientsRahul Aggarwal, Benjamin Petrie, Wasif Bala, et al.
JAMA Health Forum|August 17, 2022
Association of the Medicare Value-Based Purchasing Program With Changes in Patient Care Experience at Safety-net vs Non-Safety-net HospitalsNicholas Chiu, Rahul Aggarwal, Yang Song, et al.
Circulation. Heart Failure|December 10, 2021
Out-of-Pocket Costs for SGLT-2 (Sodium-Glucose Transport Protein-2) Inhibitors in the United StatesRahul Aggarwal, Muthiah Vaduganathan, Nicholas Chiu, et al.
Progress in Cardiovascular Diseases|September 24, 2021
Potential implications of the FDA approval of semaglutide for overweight and obese adults in the United StatesRahul Aggarwal, Muthiah Vaduganathan, Nicholas Chiu, et al.
Progress in Cardiovascular Diseases|September 4, 2025
Generalizability of SURPASS-CVOT to the United States: A Nationally Representative StudyRahul Aggarwal, Stephen J Nicholls, David D'Alessio, et al.
Dermatology (Basel, Switzerland)|July 14, 2025
Martian Dermatology: A Narrative Review of Dermatoses for Future ExplorersRyan Scheinkman, Rahul Aggarwal, Eran Gwillim, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2014
Neuroendocrine prostate cancer: subtypes, biology, and clinical outcomesRahul Aggarwal, Tian Zhang, Eric J Small, et al.
Therapeutic Advances in Medical Oncology|September 14, 2020
Dramatic response to combination pembrolizumab and radiation in metastatic castration resistant prostate cancerHarry J Han, Yun Rose Li, Mack Roach, et al.
Pageof 23